ScholarIQanswers from OpenAlex

Effect and Safety of Finerenone in Patients with IgA Nephropathy

PaperCitations, authors & open-access status

Effect and Safety of Finerenone in Patients with IgA Nephropathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Effect and Safety of Finerenone in Patients with IgA Nephropathy have?

ScholarIQcitation count

Effect and Safety of Finerenone in Patients with IgA Nephropathy has 2 citations in the OpenAlex counts ScholarIQ stores.

When was Effect and Safety of Finerenone in Patients with IgA Nephropathy published?

ScholarIQyear

Effect and Safety of Finerenone in Patients with IgA Nephropathy has 2025 year in the ScholarIQ index.

What is the open-access status of Effect and Safety of Finerenone in Patients with IgA Nephropathy?

ScholarIQoa status

Effect and Safety of Finerenone in Patients with IgA Nephropathy has gold oa status in the ScholarIQ index.

What is the DOI of Effect and Safety of Finerenone in Patients with IgA Nephropathy?

ScholarIQdoi

The DOI for Effect and Safety of Finerenone in Patients with IgA Nephropathy is on the source record.

What is the PMID of Effect and Safety of Finerenone in Patients with IgA Nephropathy?

ScholarIQpmid

The PMID for Effect and Safety of Finerenone in Patients with IgA Nephropathy is on the source record.

What is the OpenAlex record for Effect and Safety of Finerenone in Patients with IgA Nephropathy?

ScholarIQopenalex

The OpenAlex for Effect and Safety of Finerenone in Patients with IgA Nephropathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial